1740982550
Investigating HLH

Advertise on podcast: Investigating HLH

Rating
★★★★★
5
from
4 reviews
This podcast has
7 episodes
Language
English
Publisher
Sobi Inc.
Explicit
No
Date created
2024/04/12
Latest episode
2026/10/28
Average duration
30 min.
Release period
180 days

Description

Investigating HLH, brought to you by Sobi Inc., is a podcast that takes a deep dive into the complex world of hemophagocytic lymphohistiocytosis, or HLH. As a rare and fatal disease that was once considered incurable, HLH presents with a range of severe signs and symptoms that make diagnosis difficult. Join us as we discuss insights about HLH from all angles with various experts in the field of hematology-oncology who have helped to advance the understanding and treatment of this devastating disease. When treating patients with HLH, knowledge is power—because knowing what to look for can save lives.

Unlock Investigating HLH podcast Email contact info,
Listeners & Audience details

Email contact information

Direct podcast contact details

Listeners

Audience numbers & engagement insights

Audience details

Podcast Insights

Podcast episodes

Check latest episodes from Investigating HLH podcast


CXCL9 Then and Now
2026/10/28
In this episode of Investigating HLH, Kari Magee speaks with Dr Michael Jordan, Dr Sarah Nikiforow, and Dr Joseph Rocco about the story of CXCL9—where it started, how our understanding of it has evolved, and how it can help with the diagnosis and treatment of hemophagocytic lymphohistiocytosis (HLH). Dr Michael Jordan is a physician scientist and investigator at Cincinnati Children's Hospital who has studied HLH and interferon gamma biology for a number of years. Dr Sarah Nikiforow is a hematologist oncologist at Dana-Farber in Boston who treats HLH and other inflammatory syndromes in adults, sometimes taking them through hematopoietic stem cell transplantation. Dr Joseph Rocco is a clinical investigator at the National Institute of Allergy and Infectious Diseases, where he runs an HLH program focused on clinical translational science. Hear from these 3 experts on the biology that makes CXCL9 a reliable readout of interferon gamma activity, its use as a diagnostic and prognostic biomarker in children and adults, how it is interpreted alongside ferritin, soluble IL-2 receptor, and IL-18, and what they hope the future of biomarker testing will look like. Follow Us YouTube @Sobi-PharmaLinkedin @SobiPresented by Sobi Inc. https://www.sobi.com/usa/en ©2023 Sobi, Inc. All rights reserved. NP-32204 12/23 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
What Is Macrophage Activation Syndrome (MAS)?
2025/09/23
Adam Narloch speaks with Dr Randy Cron and Dr Daniella Schwartz about the pathology of macrophage activation syndrome (MAS), including its pathophysiology and relationship to hemophagocytic lymphohistiocytosis (HLH). This discussion addresses why MAS recognition can be clinically challenging and how clinicians may think about MAS in the context of hyperinflammation and rheumatologic disease. This video features expert clinician discussion and is intended for US healthcare professionals. Chapters 0:00 - What Is Macrophage Activation Syndrome (MAS)? 5:21 - MAS as a Form of Hemophagocytic Lymphohistiocytosis (HLH) 10:12 - Clinical Outcomes and Urgency in MAS 11:09 - Relationship Between MAS and HLH 18:02 - Diagnosing MAS: Criteria, Workup, and Differential Diagnosis 25:53 - Key Takeaways for MAS Recognition and Diagnosis Follow Us YouTube @Sobi-Pharma Linkedin @Sobi Presented by Sobi Inc. https://www.sobi.com/usa/en ©2023 Sobi, Inc. All rights reserved. NP-32204 12/23 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Monitoring Treatment Response
2025/02/25
Kari Magee speaks with Dr Bethany Verkamp to discuss her research on evaluating treatment response to etoposide-based treatment in patients with hemophagocytic lymphohistiocytosis (HLH). The discussion covers clinical and laboratory considerations for monitoring HLH treatment response, including how clinicians may evaluate response over time while managing HLH in patients. This video features expert clinician discussion and is intended for US healthcare professionals. Chapters 0:00 - Monitoring Hemophagocytic Lymphohistiocytosis (HLH) Treatment Response: Study Context 2:07 - Study Design: Evaluating HLH Treatment Response 9:19 - Clinical and Laboratory Response Findings in HLH 11:37 - How HCPs May Monitor Treatment Response in HLH 13:53 - Key Takeaways for HLH Response Monitoring Follow Us YouTube @Sobi-Pharma Linkedin @Sobi Presented by Sobi Inc. https://www.sobi.com/usa/en ©2023 Sobi, Inc. All rights reserved. NP-32204 12/23 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Treating Hemophagocytic Lymphohistiocytosis (HLH)
2024/06/05
Dr Saara Kaviany and Dr Blachy J. Dávila Saldaña discuss the overall treatment goals and management strategies for patients with hemophagocytic lymphohistiocytosis (HLH). The discussion focuses on clinical considerations in HLH management, treatment goals, and factors clinicians may consider when evaluating patients with HLH. This video features expert clinician discussion and is intended for US healthcare professionals. Chapters 0:00 - HLH Treatment Goals and Management Overview 5:07 - Primary HLH Treatment Goals: Stabilization, Toxicity Reduction, and HSCT Preparation 10:40 - HSCT in Primary HLH: Treatment Pathway Considerations 18:43 - Initial HLH Treatment and Hyperinflammation Control 24:59 - HLH Treatment Risks and Clinical Considerations 30:01 - Targeted Treatment Approaches in HLH 35:17 - Key Takeaways for HLH Treatment Planning Follow Us YouTube @Sobi-Pharma Linkedin @Sobi Presented by Sobi Inc. www.sobi.com ©2023 Sobi, Inc. All rights reserved. NP-32204 12/23 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Diagnosing Hemophagocytic Lymphohistiocytosis (HLH)
2024/05/15
Adam Narloch speaks with Dr Ashish Kumar and Dr Scott Canna to discuss the challenges involved with diagnosing and managing hemophagocytic lymphohistiocytosis (HLH). The discussion focuses on key considerations in HLH management, treatment goals, and clinical complexities involved in evaluating patients with HLH. This video features expert clinician discussion and is intended for US healthcare professionals. Chapters 0:00 - Why HLH Diagnosis Can Be Challenging 4:59 - Why Early and Accurate HLH Diagnosis Matters 10:10 - HLH Diagnostic Criteria and Clinical Workup 25:31 - Genetic Testing and Functional Assays for HLH 37:26 - Biomarkers in HLH Diagnosis: Ferritin, sCD25, and CXCL9 43:00 - HLH Disease Mimics and Differential Diagnosis 54:00 - HLH Guidelines: Limitations and Clinical Judgment Follow Us YouTube @Sobi-Pharma Linkedin @Sobi Presented by Sobi Inc. https://www.sobi.com/usa/en ©2023 Sobi, Inc. All rights reserved. NP-32204 12/23 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
An Introduction to Hemophagocytic Lymphohistiocytosis (HLH)
2024/04/22
Adam Narloch speaks with Dr Michelle Hermiston to discuss the history of hemophagocytic lymphohistiocytosis (HLH), advances in clinical understanding, and why recognition of this rare hyperinflammatory syndrome remains important. Topics include HLH disease awareness, primary and secondary HLH context, clinical recognition, and the evolving understanding of HLH as a serious hyperinflammatory condition. This video features expert clinician discussion and is intended for US healthcare professionals. Chapters 0:00 - What Is Hemophagocytic Lymphohistiocytosis (HLH)? 2:19 - How Clinical Understanding of HLH Has Evolved 6:46 - Immune Dysregulation and Hyperinflammation in HLH 10:16 - Interferon Gamma (IFNγ) and Proinflammatory Cytokines in HLH 14:29 - Primary vs Secondary Hemophagocytic Lymphohistiocytosis (HLH) 21:00 - Key Takeaways for HLH Recognition Follow Us YouTube @Sobi-Pharma Linkedin @Sobi Presented by Sobi Inc. https://www.sobi.com/usa/en ©2023 Sobi, Inc. All rights reserved. NP-32204 12/23 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
An Introduction to HLH
2023/11/14
In this episode of Investigating HLH, Adam Narloch, a Thought Leader Liaison at Sobi, speaks with Dr Michelle Hermiston to discuss the history of HLH and advances that have been made in understanding this rare disease. Dr Hermiston is a pediatric hematologist-oncologist, a bone marrow transplant specialist, and the director of the Pediatric Immunotherapy Program at UCSF Benioff Children’s Hospital. Join us as we start our journey into the world of HLH! Follow Us YouTube @Sobi-PharmaLinkedIn @SobiPresented by Sobi Inc. https://www.sobi.com/usa/en ©2023 Sobi, Inc. All rights reserved. NP-32204 12/23 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Podcast reviews

Read Investigating HLH podcast reviews


5 out of 5
4 reviews

Podcast sponsorship advertising

Start advertising on Investigating HLH relevant audience podcasts


What do you want to promote?